Evidence map›Paper›PMID 42048280›Full record

ArticlePLoS medicine2026

Identifying novel prodromal symptoms of eclampsia: A two-country, case-control study.

Roxanne Hastie, Farhatulain Ahmed, Parinaz Mehdipour, Bernard Yan, Susan P Walker, Jacqui Visser, Anam Bashir, Lyle Gurrin, Anthea Lindquist, Jessica A Atkinson and 3 more

Abstract read
In one paragraph

Article in PLoS medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Roxanne HastieMercy Perinatal, Mercy Hospital for Women, Heidelberg, Victoria, Australia.
Farhatulain AhmedMaternal Fetal Medicine Unit, Fatima Memorial Hospital, Lahore, Punjab, Pakistan.ORCID https://orcid.org/0000-0001-6074-8692
Parinaz MehdipourMercy Perinatal, Mercy Hospital for Women, Heidelberg, Victoria, Australia.ORCID https://orcid.org/0000-0002-1608-8487
Bernard YanDepartment of Neurology, Royal Melbourne Hospital, Melbourne, Australia.
Susan P WalkerMercy Perinatal, Mercy Hospital for Women, Heidelberg, Victoria, Australia.
Jacqui VisserDepartment of Obstetrics and Gynaecology, Stellenbosch University, Cape Town, South Africa.
Anam BashirMaternal Fetal Medicine Unit, Fatima Memorial Hospital, Lahore, Punjab, Pakistan.
Lyle GurrinMelbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.
Anthea LindquistMercy Perinatal, Mercy Hospital for Women, Heidelberg, Victoria, Australia.ORCID https://orcid.org/0000-0002-8662-5188
Jessica A AtkinsonMercy Perinatal, Mercy Hospital for Women, Heidelberg, Victoria, Australia.ORCID https://orcid.org/0000-0002-6604-7456
Catherine CluverMercy Perinatal, Mercy Hospital for Women, Heidelberg, Victoria, Australia.ORCID https://orcid.org/0000-0002-0406-8964
Lina BergmanDepartment of Obstetrics and Gynaecology, Stellenbosch University, Cape Town, South Africa.ORCID https://orcid.org/0000-0001-5202-9428
Stephen TongMercy Perinatal, Mercy Hospital for Women, Heidelberg, Victoria, Australia.ORCID https://orcid.org/0000-0002-2319-0586

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMagnesium sulphate halves the risk of eclampsia. There is no consensus on who to give magnesium sulphate prophylaxis because clinical tools are poor at identifying those at risk. Known prodromal symptoms such as headache, visual disturbance, or epigastric pain have modest associations with eclampsia. We set out to identify new prodromal symptoms of eclampsia. METHODS AND

findingsThis case-control study prospectively recruited participants in South Africa and Pakistan who had eclampsia, preeclampsia, or normotensive pregnancies. We asked whether they experienced 20 neurological symptoms, within 7 days of the seizure for those who had eclampsia. The primary analysis was the likelihood of symptoms occurring before eclampsia, compared to being present with preeclampsia. 341 participants were recruited with eclampsia, 1,355 with preeclampsia and 389 with normotensive pregnancies. When comparing symptoms among those who had eclampsia versus preeclampsia, the odds ratios (OR) were 2.56 (95% confidence interval (CI) [1.81,3.62]; p < 0.001) for headache, 5.73 (95% CI [4.44,7.39]; p < 0.001) for visual disturbances and 2.25 (95% CI [1.76,2.89]; p < 0.001) for epigastric pain. We identified 10 symptoms with odds ratios over 10 for eclampsia. Odds ratios were 42.03 (95% CI [23.66,74.68]; p < 0.001) for twitching/jerking limbs (30.5% eclampsia versus 1% preeclampsia); 36.00 (95% CI [18.34,70.65]; p < 0.001) for affected hearing (21.1% versus 0.7%)' 33.60 (95% CI [21.39,52.78]; p < 0.001) for affected mind state (38.7% versus 1.8%); 33.12 (95% CI [19.46, 54.37]; p < 0.001) for impaired speech; 23.71 (95% CI [16.49,34.10]; p < 0.001) for feelings of doom; 26.59 (95% CI [7.82,90.41]; p < 0.001) for severe vertigo; 20.52 (95% CI [14.22,29.63]; p < 0.001) for confusion; 18.16 (95% CI [10.76,30.66]; p < 0.001) for jitters; 15.18 (95% CI [11.34,20.33]; p < 0.001) for difficulty concentrating; and 10.49 (95% CI [6.76,16.27]; p < 0.001) for weakness/paralysis. These symptoms were rare among normotensive pregnancies. Only 2.4% of women with eclampsia did not experience any prodromal symptoms. This study is limited by the fact that we asked about prodromal symptoms after the seizure happened, and the potential for recall bias.

conclusionsTen prodromal symptoms exhibit far stronger associations with eclampsia than headache, visual disturbances, or epigastric pain. Eclampsia is uncommon without any prodromal symptoms. It may be useful to screen these symptoms among women with preeclampsia as part of clinical history taking to guide management. They could help direct magnesium sulphate prophylaxis to those with a higher risk of eclampsia.

Indexed as

EclampsiaProdromal SymptomsAdultCase-Control StudiesFemaleHeadacheHumansOdds RatioPakistanPre-EclampsiaPregnancyProspective StudiesRisk FactorsSouth AfricaVision DisordersYoung Adult

Identifiers

PMID42048280
PMCPMC13123989

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.